Active Ingredient: FEBUXOSTAT
Proprietary Name: ULORIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021856
Product Number: 002
Approval Date: Feb 13, 2009
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
